Literature DB >> 34395790

Investigating Neural Stem Cell and Glioma Stem Cell Self-renewal Potential Using Extreme Limiting Dilution Analysis (ELDA).

Hong Pt Nguyen1, Paul M Daniel2, Gulay Filiz2, Theo Mantamadiotis1,2,3.   

Abstract

Glioma stem cells (GSC) grown as neurospheres exhibit similar characteristics to neural stem cells (NSC) grown as neurospheres, including the ability to self-renew and differentiate. GSCs are thought to play a role in cancer initiation and progression. Self-renewal potential of GSCs is thought to reflect many characteristics associated with malignancy, including tumor recurrence following cytotoxic therapy due to their proliferative dormancy and capacity to allow for the development of resistant tumor cell sub-clones due to mutations acquired during their differentiation. Here, we demonstrate that using extreme limiting dilution analysis (ELDA), subtle differences in the frequency of sphere-forming potential between PI3K-mutant oncogenic NSCs and non-oncogenic NSCs can be measured, in vitro. We further show how ELDA can be used on cells, before and after forced differentiation to amplify inherent differences in sphere-forming potential between mutant and control NSCs. Ultimately, ELDA exploits a difference in the ability of a single or a few seeded stem cells to self-renew, divide and form neurospheres. Importantly, the assay also allows a comparison between genetically distinct cells or between the same cells under different conditions, where the impact of target-specific drugs or other novel cancer stem cell therapies can be tested.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ELDA; Glioblastoma; Glioma; Neural stem cells; Neurospheres; Self-renewal; Stem cells

Year:  2018        PMID: 34395790      PMCID: PMC8328617          DOI: 10.21769/BioProtoc.2991

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

2.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

Review 3.  The continuing evolution: biology and treatment of brain tumors.

Authors:  Andrew H Kaye; Andrew Morokoff
Journal:  Neurosurgery       Date:  2014-08       Impact factor: 4.654

4.  The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.

Authors:  François Vaillant; Marie-Liesse Asselin-Labat; Mark Shackleton; Natasha C Forrest; Geoffrey J Lindeman; Jane E Visvader
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

5.  PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein.

Authors:  Paul M Daniel; Gulay Filiz; Daniel V Brown; Michael Christie; Paul M Waring; Yi Zhang; John M Haynes; Colin Pouton; Dustin Flanagan; Elizabeth Vincan; Terrance G Johns; Karen Montgomery; Wayne A Phillips; Theo Mantamadiotis
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

Review 6.  Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain Cancer.

Authors:  Theo Mantamadiotis
Journal:  Cancers (Basel)       Date:  2017-05-30       Impact factor: 6.639

7.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

  7 in total
  4 in total

1.  Subventricular zone adult mouse neural stem cells require insulin receptor for self-renewal.

Authors:  Shravanthi Chidambaram; Fernando J Velloso; Deborah E Rothbard; Kaivalya Deshpande; Yvelande Cajuste; Kristin M Snyder; Eduardo Fajardo; Andras Fiser; Nikos Tapinos; Steven W Levison; Teresa L Wood
Journal:  Stem Cell Reports       Date:  2022-05-05       Impact factor: 7.294

2.  MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways.

Authors:  Xu Zhang; Jie Wang; Yifeng Wang; Guanzheng Liu; Huan Li; Jiefeng Yu; Runqiu Wu; Jun Liang; Rutong Yu; Xuejiao Liu
Journal:  Front Oncol       Date:  2021-01-14       Impact factor: 5.738

3.  LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.

Authors:  Yu Ding; Yingjie Li; Yunqiang Duan; Wan Wang; Wei Zheng; Weilun Cheng; Yuan Qi; Jianyuan Feng; Ziang Chen; Tianshui Yu; Anbang Hu; Ting Wang; Mingcui Li; Hanyu Zhang; Yanling Li; Fei Ma; Baoliang Guo
Journal:  J Oncol       Date:  2022-04-26       Impact factor: 4.501

4.  The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer.

Authors:  Juhong Wang; Weihao Lin; Renda Li; Hong Cheng; Sijin Sun; Fei Shao; Yannan Yang; Lin Zhang; Xiaoli Feng; Shugeng Gao; Yibo Gao; Jie He
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.